Novel insights into renal denervation

摘要

Stephen Worthley speaks to Caroline Telfer, Assistant Commissioning Editor Professor Stephen Worthley graduated in Medicine at the University of Adelaide (Australia). His training included his cardiology fellowship at the Royal Adelaide Hospital, his PhD at the Mount Sinai Medical Center in New York (USA), and postdoctoral research and interventional fellowship at Monash Medical Centre (Australia). He established the first dedicated Cardiac Computed Tomography and Magnetic Resonance units in the Asia Pacific region, as well as leading the Cardiovascular Research Centre (University of Adelaide) as the Helpman Professor of Cardiovascular Medicine, a position he has held since 2004. He has published over 150 manuscripts and five book chapters, and coedited a cardiovascular textbook. He leads a number of novel international multicenter cardiovascular therapy trials, and his clinical and research expertise spans natriuretic peptide and stem cell therapies though to transcatheter valve implantation and renal artery denervation therapy. He sits on numerous industry advisory boards, journal editorial boards and government advisory groups. In 2002, he initiated a radial artery access program at the Royal Adelaide Hospital, which rapidly evolved to become the largest volume radial access program in Australia. He is on the steering committees of interventional meetings including the ANZET and ANZET Radial meetings in Australia, and is a regular faculty member of the Trans-catheter Cardiovascular Therapeutics and EuroPCR meetings. He is internationally renowned for his interventional and imaging academic output, and early development programs for novel therapies in cardiovascular disease.